Literature DB >> 31297986

Incidence and patterns of malignancies in a multi-ethnic cohort of rheumatoid arthritis patients.

Xin Rong Lim1, Wenwei Xiang2, Justina Wei Lynn Tan1, Li Wearn Koh1, Tsui Yee Lian1, Khai Pang Leong1,2, Ee-Tzun Koh1.   

Abstract

AIM: This study was undertaken to determine the incidence and patterns of malignancies in rheumatoid arthritis (RA) patients in our cohort.
METHODS: Between 2001 and 2013, we analyzed 1117 patients in the prospective Tan Tock Seng Hospital (TTSH) RA Registry. Patients who developed malignancies after the onset of RA were identified from this registry. Age- and sex-adjusted standardized incidence ratios (SIRs) were calculated to compare observed to expected numbers of malignancies based on data from the Singapore Cancer Registry.
RESULTS: Out of 19 839 person-years of follow-up, 132 incident malignancies were diagnosed during the observation period. There were 114 (86.4%) solid-organ tumors and 18 (13.6%) hematological malignancies. The SIR (95% confidence interval) for all malignancies combined was 1.28 (0.88-1.87) for males and 1.21 (1.00-1.46) for females. Compared to the general population, we found a 4- to 5-fold increase in lymphoma among our RA patients compared to the general population (SIR 5.05 [1.90-13.46] for males and 3.75 [1.95-7.20] for females). The SIR of lung malignancy in male RA patients is 2.36 (1.23-4.53) and SIR of cervical malignancy in female RA patients is 3.72 (2.20-6.23).
CONCLUSION: There is a trend toward an overall increased malignancy risk in our RA patients compared to the general population. Specifically, there is an increased risk of lymphomas in all RA patients, lung malignancy in male patients, and cervical malignancy in female patients, compared to the general population.
© 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Singapore; cancer; malignancy; rheumatoid arthritis

Mesh:

Substances:

Year:  2019        PMID: 31297986     DOI: 10.1111/1756-185X.13655

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  Association between Rheumatoid Arthritis Disease Activity and Risk of Ovarian Malignancy in Middle-Aged and Elderly Women.

Authors:  Zhaowei Huang; Linlin Tan; Yi Ling; Fangqin Huang; Wukai Ma
Journal:  Biomed Res Int       Date:  2022-05-25       Impact factor: 3.246

2.  Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study.

Authors:  Wuu-Tsun Perng; Yao-Min Hung; Renin Chang; Cheng-Li Lin; Jeng-Yuan Chiou; Huang-Hsi Chen; Chia-Hung Kao; James Cheng-Chung Wei
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-29       Impact factor: 5.346

3.  The impact of diabetes mellitus on treatment and outcomes of rheumatoid arthritis at 5-year follow-up: results from a multi-ethnic Asian cohort.

Authors:  Chuanhui Xu; Mei Yun Yong; Ee Tzun Koh; Rinkoo Dalan; Khai Pang Leong
Journal:  Rheumatol Adv Pract       Date:  2021-11-04

4.  Functional coding haplotypes and machine-learning feature elimination identifies predictors of Methotrexate Response in Rheumatoid Arthritis patients.

Authors:  Ashley J W Lim; Lee Jin Lim; Brandon N S Ooi; Ee Tzun Koh; Justina Wei Lynn Tan; Samuel S Chong; Chiea Chuen Khor; Lisa Tucker-Kellogg; Khai Pang Leong; Caroline G Lee
Journal:  EBioMedicine       Date:  2022-01-10       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.